-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KVF6KbRWXMeoylcTWmKLXIo5h+159Q5TEYpUtL2NRU/5+3apH8izA1e/txe9nJqe UWD1EfiQjqYyE7BfI487hg== 0001209191-07-006550.txt : 20070131 0001209191-07-006550.hdr.sgml : 20070131 20070131212944 ACCESSION NUMBER: 0001209191-07-006550 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20070125 FILED AS OF DATE: 20070131 DATE AS OF CHANGE: 20070131 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PAR PHARMACEUTICAL COMPANIES, INC. CENTRAL INDEX KEY: 0000878088 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223122182 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 300 TICE BOULEVARD CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 BUSINESS PHONE: 845-425-7100 MAIL ADDRESS: STREET 1: 300 TICE BOULEVARD CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 FORMER COMPANY: FORMER CONFORMED NAME: PHARMACEUTICAL RESOURCES INC DATE OF NAME CHANGE: 19940526 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COHEN STEVEN A/SAC CAPITAL MGMT LP CENTRAL INDEX KEY: 0000905226 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10827 FILM NUMBER: 07569796 BUSINESS ADDRESS: STREET 1: C/O SAC CAPITAL ADVISORS LLC STREET 2: 72 CUMMINGS POINT ROAD CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 2038902153 MAIL ADDRESS: STREET 1: C/O SAC CAPITAL ADVISORS LLC STREET 2: 72 CUMMINGS POINT ROAD CITY: STAMFORD STATE: CT ZIP: 06902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SIGMA CAPITAL MANAGEMENT LLC CENTRAL INDEX KEY: 0001167507 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10827 FILM NUMBER: 07569797 BUSINESS ADDRESS: STREET 1: 777 LONG RIDGE ROAD CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 2036142094 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CR Intrinsic Investors, LLC CENTRAL INDEX KEY: 0001316388 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10827 FILM NUMBER: 07569798 BUSINESS ADDRESS: STREET 1: 72 CUMMINGS POINT ROAD CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 203-890-2153 MAIL ADDRESS: STREET 1: 72 CUMMINGS POINT ROAD CITY: STAMFORD STATE: CT ZIP: 06902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: S A C CAPITAL MANAGEMENT L L C CENTRAL INDEX KEY: 0001015076 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10827 FILM NUMBER: 07569799 BUSINESS ADDRESS: STREET 1: C/O 72 CUMMINGS POINT ROAD CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 2036142056 MAIL ADDRESS: STREET 1: C/O 72 CUMMINGS POINT ROAD CITY: STAMFORD STATE: CT ZIP: 06902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SAC CAPITAL ADVISORS LLC CENTRAL INDEX KEY: 0001018103 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10827 FILM NUMBER: 07569800 BUSINESS ADDRESS: STREET 1: 72 CUMMINGS POINT ROAD CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 2036142000 MAIL ADDRESS: STREET 1: 72 CUMMINGS POINT ROAD CITY: STAMFORD STATE: CT ZIP: 06902 4 1 bny29724_bny2sac.xml MAIN DOCUMENT DESCRIPTION X0202 4 2007-01-25 1 0000878088 PAR PHARMACEUTICAL COMPANIES, INC. PRX 0001018103 SAC CAPITAL ADVISORS LLC 72 CUMMINGS POINT ROAD STAMFORD CT 06902 0 0 1 0 0001015076 S A C CAPITAL MANAGEMENT L L C 540 MADISON AVENUE NEW YORK NY 10022 0 0 1 0 0001316388 CR Intrinsic Investors, LLC 72 CUMMINGS POINT ROAD STAMFORD CT 06902 0 0 1 0 0001167507 SIGMA CAPITAL MANAGEMENT LLC 540 MADISON AVENUE NEW YORK NY 10022 0 0 1 0 0000905226 COHEN STEVEN A/SAC CAPITAL MGMT LP 72 CUMMINGS POINT ROAD STAMFORD CT 06902 0 0 1 0 Common Stock 2007-01-25 4 P 0 100 24.1 A 3008000 I See footnote Common Stock 2007-01-25 4 P 0 100 24.1 A 3008100 I See footnote Equity Swap (Cash) 0 2007-01-25 4 P 0 100 24.1 A 2008-01-19 Common Stock 100 620400 I See footnote Equity Swap (Cash) 0 2007-01-25 4 P 0 200 24.01 A 2008-01-19 Common Stock 200 620600 I See footnote See Exhibit 99.2, Item 1 See Exhibit 99.2, Item 2 Please see Exhibit 99.3 attached hereto for additional Table I information. Exhibit 99.3 is a continuation of Table I. See Exhibit 99.2, Item 3 Please see Exhibit 99.4 attached hereto for additional Table II information. Exhibit 99.4 is a continuation of Table II. Exhibit List Exhibit 99.1 - Joint Filer information Exhibit 99.2 - Supplemental Information Exhibit 99.3 - Table I (cont'd) - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned Exhibit 99.4 - Table II (cont'd) - Derivative Securities Acquired, Disposed of, or Beneficially Owned /s/ Peter Nussbaum, as Authorized Person on behalf of S.A.C. CAPITAL ADVISORS, LLC 2007-01-31 /s/ Peter Nussbaum, as Authorized Person on behalf of S.A.C. CAPITAL MANAGEMENT, LLC 2007-01-31 /s/ Peter Nussbaum, as Authorized Person on behalf of CR INTRINSIC INVESTORS, LLC 2007-01-31 /s/ Peter Nussbaum, as Authorized Person on behalf of SIGMA CAPITAL MANAGEMENT, LLC 2007-01-31 /s/ Peter Nussbaum, as Authorized Person on behalf of STEVEN A. COHEN 2007-01-31 EX-99 2 form4exh991.txt ADDITIONAL EXHIBITS EXHIBIT 99.1 - FORM 4 JOINT FILER INFORMATION Name: S.A.C. Capital Management, LLC Address: 540 Madison Avenue, New York NY 10022 Designated Filer: S.A.C. Capital Advisors, LLC Issuer & Ticker Symbol: Par Pharmaceutical Companies, Inc. ("PRX") Date of Event Requiring Statement: January 25, 2007 Name: CR Intrinsic Investors, LLC Address: 72 Cummings Point Road, Stamford CT 06902 Designated Filer: S.A.C. Capital Advisors, LLC Issuer & Ticker Symbol: Par Pharmaceutical Companies, Inc. ("PRX") Date of Event Requiring Statement: January 25, 2007 Name: Sigma Capital Management, LLC Address: 540 Madison Avenue, New York NY 10022 Designated Filer: S.A.C. Capital Advisors, LLC Issuer & Ticker Symbol: Par Pharmaceutical Companies, Inc. ("PRX") Date of Event Requiring Statement: January 25, 2007 Name: Steven A. Cohen Address: 72 Cummings Point Road, Stamford CT 06902 Designated Filer: S.A.C. Capital Advisors, LLC Issuer & Ticker Symbol: Par Pharmaceutical Companies, Inc. ("PRX") Date of Event Requiring Statement: January 25, 2007 EX-99 3 form4exh992.htm ADDITIONAL EXHIBITS
Exhibit 99.2 - Supplemental Information



(1)   S.A.C. Capital Associates, LLC (“Associates”), C.R. Intrinsic Investments, LLC (“Intrinsic Investments”), and Sigma Capital Associates, LLC (“Sigma Associates”), each an Anguillan limited liability company, directly each own Common Stock of the Issuer and/or call options to purchase Common Stock of the Issuer. At 3:41 p.m., Eastern Standard Time, on January 25, 2007, Associates had direct beneficial ownership of, and each of S.A.C. Capital Advisors, LLC (“Advisors”) and S.A.C. Capital Management (“Management”) had indirect beneficial ownership of, 2,120,000 shares of Common Stock of the Issuer; Intrinsic Investments had direct beneficial ownership of, and C.R. Intrinsic Investors, LLC (“Intrinsic Investors”) had indirect beneficial ownership of, 1,030,800 shares of Common Stock of the Issuer; Sigma Associates had direct beneficial ownership of, and Sigma Capital Management, LLC (“Sigma Management”) had indirect beneficial ownership of, 440,000 shares of Common Stock of the Issuer; and Steven A. Cohen had indirect beneficial ownership of 3,590,800 shares of Common Stock of the Issuer. For purposes of this filing, the Reporting Persons have calculated the aggregate number of outstanding shares of the Issuer’s Common Stock as 35,956,798, based on the Form 10-Q, dated December 21, 2006.
 
(2)   The securities to which this report relates are held by Associates, Intrinsic Investments, and Sigma Associates. Advisors and Management are investment managers to Associates; Intrinsic Investors is an investment manager to Intrinsic Investments; and Sigma Management is an investment manager to Sigma Associates. Pursuant to investment agreements, (i) each of Advisors and Management share all investment and voting power with respect to the securities held by Associates, (ii) Intrinsic Investors maintains investment and voting power with respect to the securities held by Intrinsic Investments, and (iii) Sigma Management maintains investment and voting power with respect to the securities held by Sigma Associates. Steven A. Cohen controls each of Advisors, Management, Intrinsic Investors, and Sigma Management. Intrinsic Investments is a wholly owned subsidiary of Associates. In accordance with Instruction 5(b)(iv), the entire amount of the Issuer’s securities held by Associates, Intrinsic Investments, and Sigma Associates is reported herein. The Reporting Persons disclaim any beneficial ownership of any of the Issuer’s securities to which this report relates for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its indirect pecuniary interest therein, and this report shall not be deemed an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
 
(3)   Each of these equity swaps is a cash settled swap and thus there is no exercise date. Each of these call options is currently exercisable and became exercisable immediately upon purchase.
 

 EX-99 4 form4exh993.htm ADDITIONAL EXHIBITS
     
     
1. Name and Address of Reporting Person: S.A.C. Capital Advisors, LLC   2. Issuer Name and Ticker or Trading Symbol: Par Pharmaceutical Companies, Inc. (“PRX”)
72 Cummings Point Road, Stamford CT 06902    
     
Exhibit 99.3
Table I — Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
                                                         
                             
1. Title of Security (Instr. 3)   2. Transaction   2A. Deemed   3. Transaction   4. Securities Acquired (A) or   5. Amount of   6. Ownership   7. Nature
    Date   Execution Date,   Code   Disposed of (D)   Securities   Form:   of Indirect
        if any   (Instr. 8)   (Instr. 3, 4, and 5)   Beneficially   Direct (D) or   Beneficial
        (Month/Day/Year)                               Owned   Indirect (I)   Ownership
                                        Following   (Instr. 4)   (Instr. 4)
                                        Reported        
                                        Transaction(s)        
                                (Instr. 3 and 4)        
            Code   V   Amount   (A) or (D)   Price            
“Table I continued”
                                                       
Common Stock
  1/25/2007        P          100     (A)     24.1       3,008,200     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     24.1       3,008,300     I(1)     (2 )
Common Stock
  1/25/2007        P          200     (A)     24.09       3,008,500     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     24.1       3,008,600     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     24.1       3,008,700     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     24.1       3,008,800     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     24.1       3,008,900     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     24.1       3,009,000     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     24.1       3,009,100     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     24.1       3,009,200     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     24.1       3,009,300     I(1)     (2 )
Common Stock
  1/25/2007        P          200     (A)     24.1       3,009,500     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     24.1       3,009,600     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     24.1       3,009,700     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     24.1       3,009,800     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     24.1       3,009,900     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     24.1       3,010,000     I(1)     (2 )
Common Stock
  1/25/2007        P          700     (A)     24.1       3,010,700     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     24.1       3,010,800     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     24.1       3,010,900     I(1)     (2 )
Common Stock
  1/25/2007        P          300     (A)     24.1       3,011,200     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     24.1       3,011,300     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     24.1       3,011,400     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     24.1       3,011,500     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     24.1       3,011,600     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     24.1       3,011,700     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     24.1       3,011,800     I(1)     (2 )
Common Stock
  1/25/2007        P          300     (A)     24.1       3,012,100     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     24.1       3,012,200     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     24.1       3,012,300     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     24.1       3,012,400     I(1)     (2 )
Common Stock
  1/25/2007        P          300     (A)     24.1       3,012,700     I(1)     (2 )
Common Stock
  1/25/2007        P          200     (A)     24.11       3,012,900     I(1)     (2 )
Common Stock
  1/25/2007        P          500     (A)     23.8       3,013,400     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     23.8       3,013,500     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     23.8       3,013,600     I(1)     (2 )
Common Stock
  1/25/2007        P          400     (A)     23.81       3,014,000     I(1)     (2 )
Common Stock
  1/25/2007        P          400     (A)     23.81       3,014,400     I(1)     (2 )
Common Stock
  1/25/2007        P          200     (A)     23.81       3,014,600     I(1)     (2 )
Common Stock
  1/25/2007        P          500     (A)     23.81       3,015,100     I(1)     (2 )
Common Stock
  1/25/2007        P          300     (A)     23.81       3,015,400     I(1)     (2 )
Common Stock
  1/25/2007        P          15     (A)     23.8       3,015,415     I(1)     (2 )
Common Stock
  1/25/2007        P          500     (A)     23.81       3,015,915     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     23.81       3,016,015     I(1)     (2 )
Common Stock
  1/25/2007        P          400     (A)     23.8       3,016,415     I(1)     (2 )
Common Stock
  1/25/2007        P          85     (A)     23.8       3,016,500     I(1)     (2 )
Common Stock
  1/25/2007        P          700     (A)     23.81       3,017,200     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     23.8       3,017,300     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     23.8       3,017,400     I(1)     (2 )
Common Stock
  1/25/2007        P          400     (A)     23.81       3,017,800     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     23.8       3,017,900     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     23.8       3,018,000     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     23.8       3,018,100     I(1)     (2 )
Common Stock
  1/25/2007        P          500     (A)     23.81       3,018,600     I(1)     (2 )
Common Stock
  1/25/2007        P          300     (A)     23.79       3,018,900     I(1)     (2 )
Common Stock
  1/25/2007        P          500     (A)     23.81       3,019,400     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     23.81       3,019,500     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     23.85       3,019,600     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     23.88       3,019,700     I(1)     (2 )
Common Stock
  1/25/2007        P          600     (A)     23.88       3,020,300     I(1)     (2 )
Common Stock
  1/25/2007        P          300     (A)     23.88       3,020,600     I(1)     (2 )
Common Stock
  1/25/2007        P          800     (A)     23.86       3,021,400     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     23.86       3,021,500     I(1)     (2 )
Common Stock
  1/25/2007        P          200     (A)     23.91       3,021,700     I(1)     (2 )
Common Stock
  1/25/2007        P          800     (A)     23.91       3,022,500     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     23.88       3,022,600     I(1)     (2 )
Common Stock
  1/25/2007        P          100     (A)     23.88       3,022,700     I(1)     (2 )
Common Stock
  1/26/2007        S          200     (D)     23.97       3,022,500     I(1)     (2 )

EX-99 5 form4exh994.htm ADDITIONAL EXHIBITS
     
     
1. Name and Address of Reporting Person:
S.A.C. Capital Advisors, LLC 		  2. Issuer Name and Ticker or Trading Symbol: Par Pharmaceutical Companies, Inc. (“PRX”)
  72 Cummings Point Road, Stamford CT 06902  
     
Exhibit 99.4
Table II — Derivative Securities Acquired, Disposed of, or Beneficially Owned
                                                                                         
1. Title of   2.   3.   3A.   4.   5. Number of   6. Date Exercisable and   7. Title and Amount of   8. Price of   9. Number of   10.   11.
Derivative   Conversion   Transaction   Deemed   Transaction   Derivative   Expiration Date   Underlying Securities   Derivative   Derivative   Ownership   Nature of
Security   or Exercise   Date   Execution   Code   Securities   (Month/Day/Year)   (Instr. 3 and 4)   Security   Securities   Form of   Indirect
(Instr. 3)   Price of       Date,   (Instr. 8)   Acquired (A) or               Beneficially   Derivative   Beneficial
    Derivative       if any       Disposed of               Owned   Security   Ownership
    Security       (Month/       (D) (Instr. 3, 4,               Following   Direct (D)   (Instr. 4)
            Day/Year)       and 5)               Reported   or Indirect    
                                    Transaction(s)   (I) (Instr. 4)    
                                    (Instr. 4)        
                Code   V   (A)   (D)   Date   Expiration   Title   Amount or                    
                                Exercisable   Date       Number                    
                                            of shares                
“Table II continued”
 
                                                                                       
Equity Swap
          1/25/2007        P          100             (4)   1/31/07   Common Stock     100       23.97       620,700     (I)(1)     (2 )
Equity Swap
          1/25/2007        P          100             (4)   1/31/07   Common Stock     100       23.91       620,800     (I)(1)     (2 )
Equity Swap
          1/25/2007        P          100             (4)   1/31/07   Common Stock     100       23.9       620,900     (I)(1)     (2 )
Equity Swap
          1/25/2007        P          100             (4)   1/31/07   Common Stock     100       23.9       621,000     (I)(1)     (2 )
Equity Swap
          1/25/2007        P          100             (4)   1/31/07   Common Stock     100       23.86       621,100     (I)(1)     (2 )
Equity Swap
          1/25/2007        P          200             (4)   1/31/07   Common Stock     200       23.85       621,300     (I)(1)     (2 )
Equity Swap
          1/25/2007        P          100             (4)   1/31/07   Common Stock     100       23.79       621,400     (I)(1)     (2 )
Equity Swap
          1/25/2007        P          100             (4)   1/31/07   Common Stock     100       23.78       621,500     (I)(1)     (2 )
Equity Swap
          1/25/2007        P          4000             (4)   1/31/07   Common Stock     4000       23.8425       625,500     (I)(1)     (2 )
Equity Swap
          1/26/2007        S                  200     (4)   1/31/07   Common Stock     200       24.08       625,300     (I)(1)     (2 )
Equity Swap
          1/26/2007        S                  100     (4)   1/31/07   Common Stock     100       24.05       625,200     (I)(1)     (2 )
Equity Swap
          1/26/2007        S                  100     (4)   1/31/07   Common Stock     100       24.03       625,100     (I)(1)     (2 )
Equity Swap
          1/26/2007        S                  100     (4)   1/31/07   Common Stock     100       24.04       625,000     (I)(1)     (2 )
Call (right to buy)
    35.00     1/26/2007        S                  220     1/30/2007(4)   1/19/08   Common Stock     22,000       0.65       603,000     (I)(1)     (2 )
Call (right to buy)
    30.00     1/26/2007        S                  300     1/30/2007(4)   5/19/07   Common Stock     30,000       0.65       573,000     (I)(1)     (2 )

-----END PRIVACY-ENHANCED MESSAGE-----